Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma

by Claire Gourzones, Caroline Bret, Caroline Bret, Caroline Bret, Jerome Moreaux, Jerome Moreaux, Jerome Moreaux, Jerome Moreaux
Published 2019-09-01

Editorial: Transcriptional control in normal and malignant B-lymphocytes

by Jerome Moreaux, Jerome Moreaux, Alexander A. Shtil
Published 2023-03-01

SNaPshot as a Valuable Option for the Identification of Mutations in Myeloma

by Jerome Moreaux
Published 2015-01-01

Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma

by Sara Ovejero, Jerome Moreaux
Published 2021-02-01

Var∣Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data

by Mohammad Salma, Elina Alaterre, Jérôme Moreaux, Eric Soler
Published 2023-06-01

miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study

by Isabelle Duroux-Richard, Anne-Laure Gagez, Elina Alaterre, Rémi Letestu, Olfa Khalifa, Christian Jorgensen, Christian Jorgensen, Stéphane Leprêtre, Emmanuelle Tchernonog, Jérôme Moreaux, Jérôme Moreaux, Jérôme Moreaux, Guillaume Cartron, Guillaume Cartron, Florence Apparailly, Florence Apparailly
Published 2022-10-01

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma

by Angélique Bruyer, Laure Dutrieux, Hugues de Boussac, Thibaut Martin, Djamila Chemlal, Djamila Chemlal, Nicolas Robert, Guilhem Requirand, Guillaume Cartron, Guillaume Cartron, Laure Vincent, Charles Herbaux, Charles Herbaux, Charles Herbaux, Malik Lutzmann, Caroline Bret, Caroline Bret, Caroline Bret, Philippe Pasero, Jérôme Moreaux, Jérôme Moreaux, Jérôme Moreaux, Jérôme Moreaux, Sara Ovejero, Sara Ovejero
Published 2023-12-01

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach

by Philip Vlummens, Philip Vlummens, Stefaan Verhulst, Kim De Veirman, Anke Maes, Eline Menu, Jérome Moreaux, Jérome Moreaux, Jérome Moreaux, Hugues De Boussac, Nicolas Robert, Elke De Bruyne, Dirk Hose, Fritz Offner, Karin Vanderkerken, Ken Maes, Ken Maes
Published 2022-06-01

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets

by Ludovic Gabellier, Caroline Bret, Guillaume Bossis, Guillaume Cartron, Jérôme Moreaux
Published 2020-10-01

Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact

by Julie Devin, Alboukadel Kassambara, Angélique Bruyer, Jérôme Moreaux, Caroline Bret
Published 2019-07-01

Role of Polycomb Complexes in Normal and Malignant Plasma Cells

by Emmanuel Varlet, Sara Ovejero, Anne-Marie Martinez, Giacomo Cavalli, Jerome Moreaux
Published 2020-10-01

Transcription/Replication Conflicts in Tumorigenesis and Their Potential Role as Novel Therapeutic Targets in Multiple Myeloma

by Laure Dutrieux, Yea-Lih Lin, Malik Lutzmann, Raphaël Rodriguez, Michel Cogné, Philippe Pasero, Jérôme Moreaux
Published 2021-07-01

The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance

by Sara Ovejero, Sara Ovejero, Elena Viziteu, Elena Viziteu, Laure Dutrieux, Laure Dutrieux, Julie Devin, Julie Devin, Yea-Lih Lin, Elina Alaterre, Elina Alaterre, Michel Jourdan, Michel Jourdan, Jihane Basbous, Guilhem Requirand, Nicolas Robert, Hugues de Boussac, Anja Seckinger, Dirk Hose, Laure Vincent, Charles Herbaux, Charles Herbaux, Angelos Constantinou, Philippe Pasero, Jérôme Moreaux, Jérôme Moreaux, Jérôme Moreaux
Published 2022-12-01

Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myeloma.

by Alboukadel Kassambara, Dirk Hose, Jérôme Moreaux, Thierry Rème, Jennifer Torrent, Jean François Rossi, Hartmut Goldschmidt, Bernard Klein
Published 2012-01-01

Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells.

by Alboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, Jean-Luc Veyrune, Thierry Rème, Hartmut Goldschmidt, Dirk Hose, Bernard Klein
Published 2013-01-01

LAIR1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms

by François Van Laethem, Lucie Donaty, Emmanuelle Tchernonog, Vanessa Lacheretz-Szablewski, Jennifer Russello, Delphine Buthiau, Marion Almeras, Jérôme Moreaux, Caroline Bret
Published 2022-12-01

Characterization of human FCRL4-positive B cells.

by Michel Jourdan, Nicolas Robert, Maïlys Cren, Coraline Thibaut, Christophe Duperray, Alboukadel Kassambara, Michel Cogné, Karin Tarte, Bernard Klein, Jérôme Moreaux
Published 2017-01-01

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells

by Claire Gourzones, Céline Bellanger, Sylvain Lamure, Ouissem Karmous Gadacha, Elvira Garcia De Paco, Laure Vincent, Guillaume Cartron, Bernard Klein, Jérôme Moreaux
Published 2019-03-01

Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features

by Orianne Villard, Mathieu Armanet, Guilhem Couderc, Claire Bony, Jerome Moreaux, Daniele Noël, John DeVos, Bernard Klein, Jean-Luc Veyrune, Anne Wojtusciszyn
Published 2020-04-01

Correction to: Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features

by Orianne Villard, Mathieu Armanet, Guilhem Couderc, Claire Bony, Jerome Moreaux, Daniele Noël, John De Vos, Bernard Klein, Jean-Luc Veyrune, Anne Wojtusciszyn
Published 2020-05-01